Inovio Pharma (INO), GeneOne Approved to Conduct First-in-Man Zika Vaccine Clinical Trial
Tweet Send to a Friend
Inovio Pharmaceuticals, Inc. (Nasdaq: INO) and GeneOne Life Science, Inc. announced that they have received approval to initiate a phase ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
